Johannes Levin
johanneslevin.bsky.social
Professor for Clinical Neurodegeneration at LMU Munich; Deputy lead of clinical research at German Center for Neurodegenerative Diseases (DZNE), site Munich; Chief Medical Officer at MODAG GmbH. --> Passionate about therapy development, Bayern & Betis
👤 Joined on 19 November 2024
873
Followers
1660
Following
16
Total Posts
📜 Kullanıcı Geçmişi
- 19 Kas 2024, 06:55
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@johanneslevin.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
New paper out today at @natneuro.nature.com in collab. with DichgansLab @isd-research.bsky.social @lmumuenchen.bsky.social: We developed a fully #iPSC-derived human model of the #BBB #blood-brain-barrier and applied it to study neurovascular disease (NVD)! #OA PDF here: rdcu.be/eUIl3 Thread👇 1/10
Show Post
Today, I had the opportunity to present my research on cortical asymmetry in ADAD with @hospitalclinic.bsky.social and DIAN-OBS cohorts at the ADAD-DSAD Conference. Grateful for the chance to share our work and learn from such an inspiring community @idibaps.bsky.social @uocuniversitat.bsky.social
Show Post
Many thanks to @sebroemer.bsky.social, @matthiasbrendel.bsky.social, @johanneslevin.bsky.social, Günter Höglinger and many more
Show Post
Barbara Wendelberger, Berry Consultants, discusses Futility in Clinical Trials with JAMA Statistical Editor Roger Lewis. https://ja.ma/3ZqQV7j
Show Post
With the owner of my once beloved Twitter supporting an openly fascist party, moving here was now overdue.
Show Post